Sinsin Pharmaceutical Co. Ltd
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery … Read more
Sinsin Pharmaceutical Co. Ltd (002800) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.066x
Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has a cash flow conversion efficiency ratio of 0.066x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.70 Billion) by net assets (₩71.01 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sinsin Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Sinsin Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sinsin Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MAISON POMMERY & ASSOCIES
PA:POMRY
|
-0.070x |
|
Igarashi Motors India Limited
NSE:IGARASHI
|
0.099x |
|
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
|
-0.096x |
|
Reliance Communications Limited
NSE:RCOM
|
0.000x |
|
Woodlands Financial Services Co
PINK:WDFN
|
N/A |
|
Arich Enterprise Co Ltd
TWO:4173
|
-0.116x |
|
ROKISKIO SURIS PC EO 029
F:YTV
|
N/A |
|
BOCOM International Holdings Company Limited
F:597
|
-0.328x |
Annual Cash Flow Conversion Efficiency for Sinsin Pharmaceutical Co. Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩65.87 Billion | ₩5.94 Billion | 0.090x | +42.55% |
| 2023-12-31 | ₩62.09 Billion | ₩3.93 Billion | 0.063x | -30.80% |
| 2022-12-31 | ₩59.70 Billion | ₩5.46 Billion | 0.091x | +21570.98% |
| 2021-12-31 | ₩54.93 Billion | ₩23.18 Million | 0.000x | -98.73% |
| 2020-12-31 | ₩56.20 Billion | ₩1.87 Billion | 0.033x | +141.52% |
| 2019-12-31 | ₩56.36 Billion | ₩-4.51 Billion | -0.080x | -663.11% |
| 2018-12-31 | ₩54.54 Billion | ₩774.24 Million | 0.014x | -83.80% |
| 2017-12-31 | ₩52.12 Billion | ₩4.57 Billion | 0.088x | +8.00% |
| 2016-12-31 | ₩34.43 Billion | ₩2.79 Billion | 0.081x | -- |